Clinical Trial Update: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the optimal delay time to initiate anticoagulation after ischemic stroke in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: University of Texas at Austin | Conditions: Stroke | Phase 3 | Status: UNKNOWN